$SCPX
Scorpius Holdings, Inc. Stock $scpx

$scpx Overview Financials Valuation SEC Filings Company Website

2014 Q3 Form 10-Q Financial Statement

#000155335014000926 Filed on August 13, 2014

Income Statement

Concept	2014 Q3	2014 Q2	2013 Q2
Revenue	$9.740K	$6.546K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$830.0K	$1.010M	$440.0K
YoY Change	12.16%	129.55%	22.22%
% of Gross Profit
Research & Development	$1.025M	$849.4K	$689.0K
YoY Change	3.33%	23.28%	286.18%
% of Gross Profit
Depreciation & Amortization	$22.95K	$18.90K	$130.00
YoY Change	1767.53%	14436.92%
% of Gross Profit
Operating Expenses	$3.116M	$2.977M	$1.582M
YoY Change	58.92%	88.2%	147.54%
Operating Profit	-$3.116M	-$2.977M	-$1.582M
YoY Change	58.92%	88.2%	148.75%
Interest Expense	$8.138K		$31.80K
YoY Change	-79.97%		-417.99%
% of Operating Profit
Other Income/Expense, Net	-$11.16K	$19.08K	-$92.12K
YoY Change	-83.68%	-120.71%	624.0%
Pretax Income	-$3.130M	-$2.960M	-$1.670M
YoY Change	54.19%	77.25%	156.92%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.000M	-$2.847M	-$1.621M
YoY Change	28.82%	75.65%	145.63%
Net Earnings / Revenue	-30804.97%	-43490.91%
Basic Earnings Per Share
Diluted Earnings Per Share	-$33.33	-$31.66	-$54.00
COMMON SHARES
Basic Shares Outstanding	6.464M shares	6.452M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q3	2014 Q2	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$15.40M	$16.80M	$3.000M
YoY Change	-34.75%	460.0%
Cash & Equivalents	$3.282M	$5.983M	$3.016M
Short-Term Investments	$12.10M	$10.90M
Other Short-Term Assets	$600.0K	$700.0K	$500.0K
YoY Change	-25.0%	40.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$16.09M	$17.55M	$3.533M
YoY Change	-34.06%	396.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$464.3K	$480.9K	$9.838K
YoY Change	3444.91%	4788.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$183.5K	$21.05K	$100.0K
YoY Change		-78.95%
Total Long-Term Assets	$647.8K	$502.0K	$60.28K
YoY Change	5863.94%	732.8%
TOTAL ASSETS
Total Short-Term Assets	$16.09M	$17.55M	$3.533M
Total Long-Term Assets	$647.8K	$502.0K	$60.28K
Total Assets	$16.74M	$18.05M	$3.603M
YoY Change	-31.47%	401.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$680.5K	$720.1K	$1.319M
YoY Change	73.36%	-45.4%
Accrued Expenses	$446.2K	$320.1K	$211.6K
YoY Change	183.68%	51.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$100.0K		$200.0K
YoY Change
Total Short-Term Liabilities	$1.257M	$1.040M	$1.724M
YoY Change	119.72%	-39.67%
LONG-TERM LIABILITIES
Long-Term Debt	$1.100M	$0.00	$600.0K
YoY Change		-100.0%
Other Long-Term Liabilities			$200.0K
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$800.0K
YoY Change	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.257M	$1.040M	$1.724M
Total Long-Term Liabilities	$0.00	$0.00	$800.0K
Total Liabilities	$2.315M	$1.040M	$2.492M
YoY Change	194.43%	-58.26%
SHAREHOLDERS EQUITY
Retained Earnings			-$8.320M
YoY Change
Common Stock	$979.00	$975.00	$405.00
YoY Change	2.09%	140.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.03M	$17.49M	$1.265M
YoY Change
Total Liabilities & Shareholders Equity	$16.74M	$18.05M	$3.603M
YoY Change	-31.47%	401.15%

Cashflow Statement

Concept	2014 Q3	2014 Q2	2013 Q2
OPERATING ACTIVITIES
Net Income	-$3.000M	-$2.847M	-$1.621M
YoY Change	28.82%	75.65%	145.63%
Depreciation, Depletion And Amortization	$22.95K	$18.90K	$130.00
YoY Change	1767.53%	14436.92%
Cash From Operating Activities	-$2.850M	-$2.110M	-$1.390M
YoY Change	-1.04%	51.8%	157.41%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$440.0K	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$1.290M	$5.850M
YoY Change
Cash From Investing Activities	-$1.290M	$5.400M	$0.00
YoY Change	12800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.430M	0.000	-490.0K
YoY Change	-93.9%	-100.0%	-149.49%
NET CHANGE
Cash From Operating Activities	-2.850M	-2.110M	-1.390M
Cash From Investing Activities	-1.290M	5.400M	0.000
Cash From Financing Activities	1.430M	0.000	-490.0K
Net Change In Cash	-2.710M	3.290M	-1.880M
YoY Change	-113.19%	-275.0%	-517.78%
FREE CASH FLOW
Cash From Operating Activities	-$2.850M	-$2.110M	-$1.390M
Capital Expenditures	$0.00	$440.0K	$0.00
Free Cash Flow	-$2.850M	-$2.550M	-$1.390M
YoY Change	-1.38%	83.45%	157.41%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001476963
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6464088	shares
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	HEAT BIOLOGICS, INC.
	htbx	Amortization On Bond Premium AmortizationOnBondPremium	106762	USD
	htbx	Amortization On Bond Premium AmortizationOnBondPremium		USD
	htbx	Cashless Exercise Of Stock Option CashlessExerciseOfStockOption		USD
	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants	143190	USD
	htbx	Cashless Exercise Of Stock Warrants CashlessExerciseOfStockWarrants		USD
	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	1959570	USD
CY2014Q2	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	1113186	USD
	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	516991	USD
CY2013Q2	htbx	Clinical And Regulatory Expense ClinicalAndRegulatoryExpense	454934	USD
	htbx	Conversion Of Convertible Note Payable To Accounts Payable ConversionOfConvertibleNotePayableToAccountsPayable		USD
	htbx	Conversion Of Convertible Note Payable To Accounts Payable ConversionOfConvertibleNotePayableToAccountsPayable	197099	USD
	htbx	Noncash Investing And Financing Activities Beneficial Conversion Charge NoncashInvestingAndFinancingActivitiesBeneficialConversionCharge		USD
	htbx	Noncash Investing And Financing Activities Beneficial Conversion Charge NoncashInvestingAndFinancingActivitiesBeneficialConversionCharge	2300000	USD
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	720145	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	651917	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	320106	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	503050	USD
CY2014Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	80668	USD
CY2013Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	106462	USD
CY2014Q2	us-gaap	Accrued Rent Current AccruedRentCurrent	10262	USD
CY2013Q4	us-gaap	Accrued Rent Current AccruedRentCurrent		USD
CY2014Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28231	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9559	USD
CY2014Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	35016258	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34337591	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	497772	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	143190	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3640	USD
CY2014Q2	us-gaap	Assets Assets	18054754	USD
CY2013Q4	us-gaap	Assets Assets	23020066	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	17552785	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	22955741	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5983377	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4566992	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3015738	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5030	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1416385	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	3010708	USD
CY2014Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0002
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2014Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6464088	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6375426	shares
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6464088	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6375426	shares
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	975	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	961	USD
CY2013Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1696683	shares
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature		USD
CY2014Q2	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature		USD
	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	-2300000	USD
CY2013Q2	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature		USD
CY2014Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	19798	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	9320	USD
	us-gaap	Depreciation Depreciation	21068	USD
CY2014Q2	us-gaap	Depreciation Depreciation	18898	USD
	us-gaap	Depreciation Depreciation	944	USD
CY2013Q2	us-gaap	Depreciation Depreciation	130	USD
CY2014Q2	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	17524143	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	20600	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	100970	USD
CY2013Q4	us-gaap	Development Stage Enterprise Deficit Accumulated During Development Stage DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage	12346630	USD
CY2014Q2	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	36392	USD
CY2013Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	24946	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.80
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.44
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.55
CY2013Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.92
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	199176	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	356588	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P17M
CY2014Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2693074	USD
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
CY2013Q3	us-gaap	Equity Issuance Per Share Amount EquityIssuancePerShareAmount	10.00
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	20600	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	-143190	USD
CY2014Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	122590	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2029758	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1014888	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	706316	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	438180	USD
CY2014Q2	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	10864832	USD
CY2013Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	17297165	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	68228	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	616466	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-182944	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	82430	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-10478	USD
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits		USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	11446	USD
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	6875	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-25364	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	29746	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-398454	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	441940	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash		USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	152	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	17521	USD
CY2014Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6546	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	2	USD
CY2013Q2	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1	USD
	us-gaap	Interest Expense InterestExpense		USD
CY2014Q2	us-gaap	Interest Expense InterestExpense		USD
	us-gaap	Interest Expense InterestExpense	60141	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	31799	USD
	us-gaap	Interest Paid InterestPaid		USD
	us-gaap	Interest Paid InterestPaid	17445	USD
CY2014Q2	us-gaap	Interest Payable Current InterestPayableCurrent		USD
CY2013Q4	us-gaap	Interest Payable Current InterestPayableCurrent	25364	USD
CY2014Q2	us-gaap	Liabilities Liabilities	1040251	USD
CY2013Q4	us-gaap	Liabilities Liabilities	1302921	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18054754	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-1620774	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-203810	USD
CY2014Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-111442	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23020066	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1040251	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1180331	USD
CY2014Q2	us-gaap	Minority Interest MinorityInterest	-478587	USD
CY2013Q4	us-gaap	Minority Interest MinorityInterest	-274777	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	37719	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4904580	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	5877337	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4498671	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1893872	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5177513	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	-2846915	USD
	us-gaap	Net Income Loss NetIncomeLoss	-4684630	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-78046	USD
CY2013Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-53441	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9008	USD
CY2014Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	19076	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-110101	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-92122	USD
	us-gaap	Operating Expenses OperatingExpenses	5372315	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	2977433	USD
	us-gaap	Operating Expenses OperatingExpenses	2352575	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	1582093	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5372315	USD
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2977433	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2352575	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1582093	USD
CY2014Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	30000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	40000	USD
CY2014Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21050	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10572	USD
CY2014Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	122590	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-26529	USD
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12530	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-49962	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-60324	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	145510	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	448234	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	3305972	USD
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		USD
CY2014Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	668184	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1066638	USD
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1000000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1000000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	25000000	USD
CY2013Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	27000000	USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	9631543	USD
	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments		USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	37719	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		USD
	us-gaap	Profit Loss ProfitLoss	-5381323	USD
CY2014Q2	us-gaap	Profit Loss ProfitLoss	-2958357	USD
	us-gaap	Profit Loss ProfitLoss	-2462676	USD
CY2013Q2	us-gaap	Profit Loss ProfitLoss	-1674215	USD
CY2014Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	509150	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63312	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	480919	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53753	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1382987	USD
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	849359	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1129268	USD
CY2013Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	688979	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1252	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.09	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0223	pure
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	404672	shares
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1252	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	497772	USD
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	328660	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	183575	USD
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	156782	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.03
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	22428	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.93
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	293879	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.09
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	837139	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	633482	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.72
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.36
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y9M18D
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	404672	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.03
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.69
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	6.43
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1840048	shares
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	17493090	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	21991922	USD
CY2014Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17014503	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21717145	USD
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	1761962	shares
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	37719	USD
CY2013Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.4348	pure
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100000	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	100000	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	2500000	shares
CY2013Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	36167	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	67794	shares
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	930000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	930000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22400000	USD
CY2013Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	24300000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6432857	shares
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6452986	shares

Files In Submission

Name	View Source	Status
0001553350-14-000926-index-headers.html	Edgar Link	pending
0001553350-14-000926-index.html	Edgar Link	pending
0001553350-14-000926.txt	Edgar Link	pending
0001553350-14-000926-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
htbx-20140630.xml	Edgar Link	completed
htbx-20140630.xsd	Edgar Link	pending
htbx-20140630_cal.xml	Edgar Link	unprocessable
htbx-20140630_def.xml	Edgar Link	unprocessable
htbx-20140630_lab.xml	Edgar Link	unprocessable
htbx-20140630_pre.xml	Edgar Link	unprocessable
htbx_10q.htm	Edgar Link	pending
htbx_ex31z1.htm	Edgar Link	pending
htbx_ex31z2.htm	Edgar Link	pending
htbx_ex32z1.htm	Edgar Link	pending
htbx_ex32z2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SCPX
Scorpius Holdings, Inc. Stock $scpx

2014 Q3 Form 10-Q Financial Statement

#000155335014000926 Filed on August 13, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX Scorpius Holdings, Inc. Stock $scpx

2014 Q3 Form 10-Q Financial Statement

#000155335014000926 Filed on August 13, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SCPX
Scorpius Holdings, Inc. Stock $scpx